(Q37994139)

26 August 2017

title

Clinical cofactors and hepatic fibrosis in hereditary hemochromatosis: the role of diabetes mellitus (English)

1 reference

26 August 2017

Marnie J Wood

1

1 reference

26 August 2017

Lawrie W Powell

series ordinal

2

1 reference

26 August 2017

Jeannette L Dixon

series ordinal

3

1 reference

26 August 2017

Grant A Ramm

series ordinal

4

1 reference

26 August 2017

language of work or name

English

0 references

publication date

19 June 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

56

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

904-911

1 reference

A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis

26 August 2017

cites work

1 reference

Iron-overload-related disease in HFE hereditary hemochromatosis

21 January 2018

1 reference

A population-based study of the clinical expression of the hemochromatosis gene

21 January 2018

1 reference

Screening for hemochromatosis in asymptomatic subjects with or without a family history

21 January 2018

1 reference

Liver diseases in the hemochromatosis and iron overload screening study.

21 January 2018

1 reference

Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis

21 January 2018

1 reference

Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation

21 January 2018

1 reference

Steatosis is a cofactor in liver injury in hemochromatosis

21 January 2018

1 reference

National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants

21 January 2018

1 reference

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

21 January 2018

1 reference

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis.

21 January 2018

1 reference

Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol

21 January 2018

1 reference

Contribution of obesity to hepatitis C-related fibrosis progression

21 January 2018

1 reference

Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus

21 January 2018

1 reference

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

21 January 2018

1 reference

Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C.

21 January 2018

1 reference

Excess weight risk factor for alcoholic liver disease

21 January 2018

1 reference

Risk factors of fibrosis in alcohol-induced liver disease

21 January 2018

1 reference

Impact of body mass index and viral load on liver histology in hepatitis B e antigen-negative chronic hepatitis B.

21 January 2018

1 reference

Survival and causes of death in hemochromatosis. Observations in 163 patients

21 January 2018

1 reference

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

Standards of medical care in diabetes--2011.

21 January 2018

1 reference

Serum ferritin concentration and iron stores in normal subjects

21 January 2018

1 reference

Classification of chronic viral hepatitis: a need for reassessment

21 January 2018

1 reference

Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis

21 January 2018

1 reference

Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors

21 January 2018

1 reference

Hyperglycemia-induced mitochondrial alterations in liver

21 January 2018

1 reference

Iron Homeostasis, Hepatocellular Injury, and Fibrogenesis in Hemochromatosis: The Role of Inflammation in a Noninflammatory Liver Disease

21 January 2018

1 reference

Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.

21 January 2018

1 reference

High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis

21 January 2018

1 reference

Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target

21 January 2018

1 reference

Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

Cigarette smoking and chronic liver diseases

21 January 2018

1 reference

Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease

21 January 2018

1 reference

Hepatitis C, iron status, and disease severity: relationship with HFE mutations

21 January 2018

1 reference

7 January 2021

Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings

1 reference

7 January 2021

The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis

1 reference

7 January 2021

Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B

1 reference

7 January 2021

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

1 reference

7 January 2021

Long-term survival in patients with hereditary hemochromatosis

1 reference

7 January 2021

The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.25720

1 reference

26 August 2017

1 reference